Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Buy or sell: Vaishali Parekh recommends three intraday stocks for today - 12 March 2026
The Indian stock market struggled on March 11, with significant losses in the Nifty 50 and BSE Sensex driven by high energy costs and inflation fears. Profit booking dominated all major sectors, especially autos and banking, as investors remained cautious amid geopolitical uncertainties.
Stocks to buy in 2026 for long term: Ambuja Cement, Apollo Hospitals among 5 stocks that could give 10-30% return
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
Top Gainers & Losers on Feb 26: Tejas Networks, KSB, Mankind Pharma, Tata Motors, Finolex Cables among top gainers
The Indian stock market remained largely unchanged on February 26, with the Nifty 50 up 0.06% at 25,496 and the S&P BSE Sensex flat at 82,248. Broader markets showed mixed results, while US stocks rallied on Nvidia's strong earnings, boosting Asian markets as well.
Nifty Pharma index soars 7% thus far in February; nears 52-week high
Thus far in the month of February 2026, Laurus Labs surged 13%, while Sun Pharmaceutical Industries and Torrent Pharmaceuticals soared 11% each.
Taking Stock: Markets rebound; Nifty reclaims 24,150, Sensex jumps 600 pts
Among the top gainers on the index were Maruti Suzuki India, Coal India, Tech Mahindra, ITC Limited, and Reliance Industries. On the downside, InterGlobe Aviation, Dr. Reddy's Laboratories, NTPC, ICICI Bank and Bajaj Finserv were among the key laggards.
Nippon India MF buys additional over 1 percent stake in Sanofi India
Nippon Life India Trustee through Nippon India Small Cap Fund already held 3.79 percent equity stake in Sanofi India as of March 2026.
Taking Stock: Sensex, Nifty end flat ahead of RBI policy; consumer durables, capital goods shine
More than 120 stocks touched their 52-week high on the BSE, including Cemindia Projects, Nippon Life India Asset Management, Jindal Saw, HFCL, Syrma SGS, Laurus Labs, Polycab, Vodafone Idea, Federal Bank, IFCI, JK Bank, Welspun Corp, RBL Bank, among others.
Nifty recovers 200 points from intra-day lows; IT continues outperformance | Closing Bell
Indian equities erased all the intraday losses with Nifty back above 23,500. TCS, Infosys, HCL Tech, Tech Mahindra, Trent are among top gainers on the Nifty, while losers are NTPC, Power Grid Corp, Cipla, Dr Reddy's Labs and L&T. Among sectors IT index up 4%, while auto, metal, Consumer Durables, realty up 0.5% each. However, pharma, healthcare, power, media, energy down 0.5-1%. Nifty Midcap and Smallcap indices down marginally. Catch Lovish Darad in conversation with Market Experts.
SBI MF, Nippon India MF buy Rs 272 crore worth Pine Labs shares; ICICI Pru MF acquire 1.5% stake in Indoco Remedies
SBI Mutual Fund through SBI Midcap Fund held 5.24 percent stake in Pine Labs, the point of sale and payment systems provider, as of March 2026.
Cipla stock up 4% to emerge as top Nifty gainer; Citi sees series of near-term positive US triggers
The stock was trading at Rs 1,407, up 4.08 percent.
Dr Reddy’s stock up over 1%, among top Nifty gainers today; Nomura bullish on branded drugs push; check upside
The brokerage said Dr Reddy's strategic focus is increasingly shifting towards branded generics and consumer healthcare businesses, with recent acquisitions largely aimed at strengthening its branded portfolio.
Nifty Pharma jumps nearly 2%; Dr Reddy's, Sun Pharma and Cipla lead gains, dominate Nifty gainers list
Pharma stocks led the gains on benchmark Nifty 50 and the BSE Midcap index on Tuesday. Dr Reddy's, Sun Pharma and Cipla were the top 3 Nifty gainers, amid news reports that the US FDA has asked Indian firms to help address a shortage of ifosfamide injection.